Imipramine updated on 07-01-2025

Low Apgar score (< 7) (at 1 min)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18430
R78006
Lee (Controls exposed to SSRI), 2025 1-minute Apgar score <7 during pregnancy (anytime or not specified) retrospective cohort (claims database) exposed to other treatment, sick excluded Adjustment: No Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) 0.30 [0.04;2.21] C
excluded (control group)
1/64   73/1,465 74 64
ref
S18416
R77868
Lee (Controls unexposed, general pop), 2025 1-minute Apgar score <7 during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) 0.36 [0.05;2.57] 1/64   14,883/463,440 14,884 64
ref
Total 1 studies 0.36 [0.05;2.58] 14,884 64
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Lee (Controls unexposed, general pop), 2025Lee, 2025 1 0.36[0.05; 2.57]14,884640%ROB confusion: moderateROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate0.22.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, general pop;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0.36[0.05; 2.58]14,88464 -NALee (Controls unexposed, general pop), 2025 1 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 0.36[0.05; 2.58]14,88464 -NALee (Controls unexposed, general pop), 2025 1 Tags Adjustment   - Yes  - Yes 0.36[0.05; 2.58]14,88464 -NALee (Controls unexposed, general pop), 2025 1 Monotherapy   - substance alone among all Antidep ( ...  - substance alone among all Antidep (SSRI, SNRI, ...) 0.36[0.05; 2.58]14,88464 -NALee (Controls unexposed, general pop), 2025 1 All studiesAll studies 0.36[0.05; 2.58]14,88464 -NALee (Controls unexposed, general pop), 2025 10.110.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 18430

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) Out of scale0.36[0.05; 2.58]14,88464 -NALee (Controls unexposed, general pop), 2025 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls Out of scale0.30[0.04; 2.21]7464 -NALee (Controls exposed to SSRI), 2025 10.510.01.0